Researchers take important step toward gonorrhea vaccine

Researchers are paving the way toward a new therapeutic approach for gonorrhea by shedding light on the mechanism behind important proteins on the Neisseria gonorrhoeae bacteria’s outer membrane. 

Conference at OSU explores intravenous vitamin C as treatment for cancer, sepsis

The Linus Pauling Institute will host its biennial “Diet and Optimum Health” conference Sept. 13-16, attracting an international audience of experts in nutrition, preventive medicine and oncology.

Oregon State University agricultural sciences, pharmacy deans transition

Dan Arp, dean of the College of Agricultural Sciences, and Mark Zabriskie, dean of the College of Pharmacy, will step down from these university leadership roles effective June 30, 2018. 

New gonorrhea treatment targets enzyme needed for respiration

Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.

Patients nearing end of life receptive to having cholesterol medicine 'deprescribed'

Research suggests patients nearing the end of their lives because of a “life-limiting illness” may not feel medically abandoned if their doctor wants to take them off cholesterol medicine.

Blocking TB germs' metabolic 'escape pathways' may be key to better, shorter treatment

Research suggests the bacteria that cause TB alter their metabolism to combat exposure to antimicrobials, and that the metabolic mechanisms might be neutralized by new drugs.

New drug delivery system shows promise for fighting solid tumors

A new cancer-drug delivery system shows the ability to exploit the oxygen-poor areas of solid tumors that make the growths resistant to standard chemotherapy and radiation treatment.

Altered lipids, skin infections may point to new personalized therapy for atopic dermatitis

Researchers have made a fundamental advance in dermatology that could lead to new therapies for millions of people with atopic dermatitis, one of the most common forms of eczema.

Research outlines how low-dose aspirin can help prevent cancer

Researchers have outlined for the first time a key mechanism by which low-dose aspirin may inhibit cancer cell proliferation and metastasis.

Pages